Canadian-based Prollenium Medical Technologies produces cutting-edge products. Revanesse® dermal fillers containing cross-linked hyaluronic acid are characterised by their high safety and long-term effect. Revanesse® injectable fillers are of non-animal origin, have a high viscosity and therefore form a thicker gel. The Revanesse® brand offers products that fill deep wrinkles, lines and skin defects, as well as products designed for volumetric modelling of the face, for example the cheeks. The long-term effect is visible for up to 18 months after application.

Your message has been successfully sent

Unable to send.

Are you a specialist working in the health sector?
I am a doctor or a specialist, i.e. a person authorised to prescribe drugs or a person authorised to dispense drugs.
I hereby confirm that I am familiar with any risks that a person other than a specialist may face if they enter a website designed exclusively for specialists.